Synthesis of radiolabeled racemic and enanthiomeric antiarrhythmic agents

Ventricular fibrillation is a leading cause of fatality in patients suffering from cardiovascular disorders. Among approaches to treating cardiac dysrhythmia with medicinal agents is the use of compounds categorized as open-quotes Class IIIclose quotes antiarrhythmic agents to prolong cardiac action potential and increase the refractoriness of cardiac tissues without affecting the sodium current. Investigations into structural requirements necessary for such biological activities led to the synthesis of a series of aniline-propanolamine derivatives. This report describes the preparation of carbon-14 and tritium labeled forms of racemic and enantiomeric forms of these derivatives for conducting drug disposition studies in test animals and human subjects